FDANonrulemakingFDA-2018-N-4087

Who commented on this docket

FDA’s Proposed Current Good Manufacturing Practice Policies for Outsourcing Facilities: Considerations Regarding Access to Office Stock; Public Meeting.

1 organizations filed 1 public comment on FDA’s Proposed Current Good Manufacturing Practice Policies for Outsourcing Facilities: Considerations Regarding Access to Office Stock; Public Meeting., at the Food and Drug Administration. The comment window closed 2594d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 2594d ago

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.